Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Overactive Bladder

Interventions

BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A injection into the detrusor.

DRUG

Normal Saline (Placebo)

Placebo (Normal Saline) injection into the detrusor.

Trial Locations (4)

Philadelphia

Herston

Victoria

Chennai